Annual CFI
$71.04 M
+$13.18 M+22.77%
December 31, 2023
Summary
- As of February 21, 2025, BOLT annual cash flow from investing activities is $71.04 million, with the most recent change of +$13.18 million (+22.77%) on December 31, 2023.
- During the last 3 years, BOLT annual CFI has risen by +$91.63 million (+444.98%).
- BOLT annual CFI is now at all-time high.
Performance
BOLT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$17.14 M
-$865.00 K-4.80%
September 30, 2024
Summary
- As of February 21, 2025, BOLT quarterly cash flow from investing activities is $17.14 million, with the most recent change of -$865.00 thousand (-4.80%) on September 30, 2024.
- Over the past year, BOLT quarterly CFI has dropped by -$865.00 thousand (-4.80%).
- BOLT quarterly CFI is now -58.04% below its all-time high of $40.84 million, reached on March 31, 2022.
Performance
BOLT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$61.15 M
+$4.48 M+7.90%
September 30, 2024
Summary
- As of February 21, 2025, BOLT TTM cash flow from investing activities is $61.15 million, with the most recent change of +$4.48 million (+7.90%) on September 30, 2024.
- Over the past year, BOLT TTM CFI has increased by +$4.48 million (+7.90%).
- BOLT TTM CFI is now -14.67% below its all-time high of $71.66 million, reached on September 30, 2023.
Performance
BOLT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BOLT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.8% | -4.8% | +7.9% |
| 3 y3 years | +445.0% | -4.8% | +7.9% |
| 5 y5 years | +10000.0% | -4.8% | +7.9% |
BOLT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +130.6% | -58.0% | +2074.4% | -14.7% | +126.3% |
| 5 y | 5-year | at high | +130.6% | -58.0% | +109.0% | -14.7% | +124.3% |
| alltime | all time | at high | +130.6% | -58.0% | +109.0% | -14.7% | +124.3% |
Bolt Biotherapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $17.14 M(-4.8%) | $61.15 M(+7.9%) |
| Jun 2024 | - | $18.00 M(+76.4%) | $56.67 M(+8.5%) |
| Mar 2024 | - | $10.20 M(-35.5%) | $52.25 M(-26.4%) |
| Dec 2023 | $71.04 M(+22.8%) | $15.81 M(+24.9%) | $71.04 M(-0.9%) |
| Sep 2023 | - | $12.66 M(-6.8%) | $71.66 M(+18.5%) |
| Jun 2023 | - | $13.58 M(-53.2%) | $60.46 M(+31.4%) |
| Mar 2023 | - | $28.99 M(+76.4%) | $46.01 M(-20.5%) |
| Dec 2022 | $57.86 M | $16.43 M(+1033.4%) | $57.86 M(-7.4%) |
| Sep 2022 | - | $1.45 M(-267.1%) | $62.46 M(+39.1%) |
| Jun 2022 | - | -$868.00 K(-102.1%) | $44.90 M(-5477.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $40.84 M(+94.2%) | -$835.00 K(-99.6%) |
| Dec 2021 | -$232.20 M(+1027.6%) | $21.03 M(-230.6%) | -$232.20 M(-7.7%) |
| Sep 2021 | - | -$16.11 M(-65.4%) | -$251.53 M(+1.2%) |
| Jun 2021 | - | -$46.60 M(-75.5%) | -$248.51 M(+25.8%) |
| Mar 2021 | - | -$190.52 M(<-9900.0%) | -$197.50 M(+859.1%) |
| Dec 2020 | -$20.59 M(+3953.5%) | $1.70 M(-113.0%) | -$20.59 M(-7.6%) |
| Sep 2020 | - | -$13.10 M(-397.1%) | -$22.30 M(+142.3%) |
| Jun 2020 | - | $4.41 M(-132.4%) | -$9.20 M(-32.4%) |
| Mar 2020 | - | -$13.61 M | -$13.61 M |
| Dec 2019 | -$508.00 K(+75.2%) | - | - |
| Dec 2018 | -$290.00 K | - | - |
FAQ
- What is Bolt Biotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual CFI year-on-year change?
- What is Bolt Biotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly CFI year-on-year change?
- What is Bolt Biotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics TTM CFI year-on-year change?
What is Bolt Biotherapeutics annual cash flow from investing activities?
The current annual CFI of BOLT is $71.04 M
What is the all time high annual CFI for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual cash flow from investing activities is $71.04 M
What is Bolt Biotherapeutics annual CFI year-on-year change?
Over the past year, BOLT annual cash flow from investing activities has changed by +$13.18 M (+22.77%)
What is Bolt Biotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BOLT is $17.14 M
What is the all time high quarterly CFI for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly cash flow from investing activities is $40.84 M
What is Bolt Biotherapeutics quarterly CFI year-on-year change?
Over the past year, BOLT quarterly cash flow from investing activities has changed by -$865.00 K (-4.80%)
What is Bolt Biotherapeutics TTM cash flow from investing activities?
The current TTM CFI of BOLT is $61.15 M
What is the all time high TTM CFI for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high TTM cash flow from investing activities is $71.66 M
What is Bolt Biotherapeutics TTM CFI year-on-year change?
Over the past year, BOLT TTM cash flow from investing activities has changed by +$4.48 M (+7.90%)